Biochemistry, Genetics and Molecular Biology
T Cell
45%
Gene Expression Profiling
37%
Mouse
33%
APOBEC
33%
Clinical Trial
33%
RNA Sequence
31%
Transcriptomics
31%
Immunocompetent Cell
28%
Circulating Tumor DNA
28%
Cell Cycle
28%
Genome Instability
28%
Proteomics
27%
Cell Infiltration
22%
Chromosome Instability
22%
Papillary Tumor
22%
Supernatant
22%
Real-Time Polymerase Chain Reaction
22%
Oxygen Concentration
22%
Volume
22%
Folate Receptor 1
22%
Preimplantation
22%
Bacilli
22%
Gene Signature
22%
Morphology
22%
Allele
22%
Genomics
22%
Phenotypic Variation
22%
Blood Sampling
22%
Nucleic Acid
22%
Cancer Staging
22%
T Cell Receptor
22%
Folliculogenesis
16%
Urine Sampling
16%
Dynamics
15%
Biomarker Discovery
11%
Subtyping
11%
RNA
11%
DNA Template
11%
Preclinical Study
11%
Small Interfering RNA
11%
Transcriptome
11%
Laser Capture Microdissection
11%
P53
11%
RNA Degradation
11%
Microdissection
11%
Tumor Volume
11%
ARID1A
11%
CD8
11%
Angiogenesis
11%
Urine Level
11%
Medicine and Dentistry
Neoplasm
100%
Bladder Cancer
90%
Mutational Analysis
45%
Circulating Tumor DNA
25%
RNA Sequence
24%
Tumor Xenograft
22%
Hypoxia
22%
Prostate Cancer
22%
Muscle Invasive Bladder Cancer
22%
Neoadjuvant Chemotherapy
22%
T Cell Development
22%
Carcinoma in Situ
22%
Transitional Cell Carcinoma
22%
Circulating Tumor Cell
22%
Urinary System
18%
Bladder Tumor
14%
Treatment Response
13%
Non Muscle Invasive Bladder Cancer
11%
Papilloma
11%
In Vitro
11%
Real Time Polymerase Chain Reaction
11%
Pimonidazole
11%
Adenocarcinoma
11%
Xenograft
11%
Autoradiograph
11%
Head and Neck Squamous Cell Carcinoma
11%
Fluorine-18
11%
Recurrent Disease
10%
Bladder
10%
Disease
10%
Risk Stratification
9%
Transcriptomics
9%
Malignant Neoplasm
8%
Bladder Biopsy
7%
Proportional Hazards Model
7%
Outcome Assessment
7%
Proteomics
7%
Clinical Study
5%
Laser Capture Microdissection
5%
RNA Degradation
5%
DNA Template
5%
Cell Line
5%
Biological Marker
5%
Clinical Trial
5%
Prognostication
5%
Disease Surveillance
5%
Diseases
5%
Minimal Residual Disease
5%
Biopsy Technique
5%
Liquid Biopsy
5%
Keyphrases
Bladder Cancer
22%
Tumor mutation Burden
22%
Field Cancerization
22%
Mutational Analysis
22%
DNA mutational Analysis
22%
Urine DNA
22%
Neoadjuvant Chemotherapy Response
22%
Chemotherapy Outcomes
22%
Tumor
22%
T-cell Receptor Repertoire
22%
Urine Supernatant
16%
Nontumor
15%
Bladder
15%
Expanded Clones
11%
Driver mutations
7%
Bladder Tumor
7%
Urothelium
7%
Tumor-normal
7%
Unifocal
7%
Functional Impact
7%
Multifocal Disease
7%
Deep Targeted Sequencing
7%
One Field
7%
Mutant Allele Frequency
7%
Uncommon mutation
7%
Molecular Changes
7%
Cancer Driver Genes
7%
APOBEC
7%
Read Depth
7%
Mutational Landscape
7%
Cancer Patients
7%
Tumor-specific
7%
Tumor Samples
7%
DNA Dynamics
5%
Immune Composition
5%
Immune Cell Exhaustion
5%
Shallow Whole Genome Sequencing (sWGS)
5%
Integrative Clustering
5%
Genomically Stable
5%
Cell Cycle Genes
5%
Disease Surveillance
5%
Urinary System Tumors
5%
Circulating nucleic Acids
5%
Longitudinal Testing
5%
